Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 juil. 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., July 06, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
14 juin 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London

DUBLIN, Ireland and TREVOSE, Pa., June 14, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
09 juin 2016 16h15 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Executive Promotion and Leadership Transition

DUBLIN, Ireland and TREVOSE, Pa., June 09, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...
02 juin 2016 16h05 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., June 02, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
31 mai 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology

DUBLIN, Ireland and TREVOSE, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...
17 mai 2016 08h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Reports First Quarter 2016 Financial Results

DUBLIN and TREVOSE, Pa., May 17, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and commercialization...
05 mai 2016 09h00 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Bio€quity Europe 2016

DUBLIN and TREVOSE, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and commercialization...
06 avr. 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at 15th Annual Needham Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., April 06, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
04 avr. 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation of COR-003 Data at the Endocrine Society’s 2016 Annual Conference

DUBLIN, Ireland and TREVOSE, Pa., April 04, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...
24 mars 2016 07h30 HE | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Reports Full-Year 2015 Financial Results

DUBLIN, Ireland and TREVOSE, Pa., March 24, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...

Page précédente